These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 741439)

  • 21. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin.
    Laugen RH; Bithell TC
    Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L; Koopman J; de Munk G; Haverkate F; Nováková I; Verheijen JH; Briët E; Brommer EJ
    Thromb Haemost; 1988 Aug; 60(1):113-20. PubMed ID: 3142089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V; Regañón E; Aznar J; Navarro G; Salas M
    Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence.
    Torbet J
    Biochem J; 1987 Jun; 244(3):633-7. PubMed ID: 3446182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.
    Higgins DL; Penner JA; Shafer JA
    Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinogen Marburg a new genetic variant of fibrinogen.
    Fuchs G; Egbring R; Havemann K
    Blut; 1977 Feb; 34(2):107-18. PubMed ID: 836966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital dysfibrinogenemia: fibrinogen Detroit.
    Mammen EF; Prasad AS; Barnhart MI; Au CC
    J Clin Invest; 1969 Feb; 48(2):235-49. PubMed ID: 4974308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 35. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fibrinogen. Hereditary hypo--and dysfibrinogenemia].
    Gajdos A
    Nouv Presse Med; 1973 Apr; 2(16):1067-71. PubMed ID: 4267566
    [No Abstract]   [Full Text] [Related]  

  • 37. Unique pattern of fibrinogen cleavage by human leukocyte proteases.
    Bilezikian SB; Nossel HL
    Blood; 1977 Jul; 50(1):21-8. PubMed ID: 871524
    [No Abstract]   [Full Text] [Related]  

  • 38. [Congenital dysfibrinogenemia: fibrinogen Giessen II].
    Krause WH; Heene DL; Lasch HG; Huth K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1646-9. PubMed ID: 1030068
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fibrinogen Awaji: a congenital dysfibrinogenemia characterized by abnormal fibrin monomer polymerization].
    Matsuo T; Okuno S; Mukaida T; Matsuo O
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1594-7. PubMed ID: 4090933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.